207 related articles for article (PubMed ID: 28078827)
21. Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets.
Boyault S; Rickman DS; de Reyniès A; Balabaud C; Rebouissou S; Jeannot E; Hérault A; Saric J; Belghiti J; Franco D; Bioulac-Sage P; Laurent-Puig P; Zucman-Rossi J
Hepatology; 2007 Jan; 45(1):42-52. PubMed ID: 17187432
[TBL] [Abstract][Full Text] [Related]
22. Concordance of copy number loss and down-regulation of tumor suppressor genes: a pan-cancer study.
Zhao M; Zhao Z
BMC Genomics; 2016 Aug; 17 Suppl 7(Suppl 7):532. PubMed ID: 27556634
[TBL] [Abstract][Full Text] [Related]
23. Identification of genes involved in squamous cell carcinoma of the lung using synchronized data from DNA copy number and transcript expression profiling analysis.
Lo KC; Stein LC; Panzarella JA; Cowell JK; Hawthorn L
Lung Cancer; 2008 Mar; 59(3):315-31. PubMed ID: 18029052
[TBL] [Abstract][Full Text] [Related]
24. Multi-omics approach to infer cancer therapeutic targets on chromosome 20q across tumor types.
Snijders AM; Mao JH
Adv Mod Oncol Res; 2016; 2(4):215-223. PubMed ID: 27642640
[TBL] [Abstract][Full Text] [Related]
25. Somatic alterations of targetable oncogenes are frequently observed in BRCA1/2 mutation negative male breast cancers.
Rizzolo P; Navazio AS; Silvestri V; Valentini V; Zelli V; Zanna I; Masala G; Bianchi S; Scarnò M; Tommasi S; Palli D; Ottini L
Oncotarget; 2016 Nov; 7(45):74097-74106. PubMed ID: 27765917
[TBL] [Abstract][Full Text] [Related]
26. The chromosome 3q26 OncCassette: A multigenic driver of human cancer.
Fields AP; Justilien V; Murray NR
Adv Biol Regul; 2016 Jan; 60():47-63. PubMed ID: 26754874
[TBL] [Abstract][Full Text] [Related]
27. Mechanism of carcinogenesis: the role of oncogenes, transcriptional enhancers and growth factors.
Spandidos DA
Anticancer Res; 1985; 5(5):485-98. PubMed ID: 3904595
[TBL] [Abstract][Full Text] [Related]
28. Intertumor heterogeneity of non-small-cell lung carcinomas revealed by multiplexed mutation profiling and integrative genomics.
Tan DS; Camilleri-Broët S; Tan EH; Alifano M; Lim WT; Bobbio A; Zhang S; Ng QS; Ang MK; Iyer NG; Takano A; Lim KH; Régnard JF; Tan P; Broët P
Int J Cancer; 2014 Sep; 135(5):1092-100. PubMed ID: 24482041
[TBL] [Abstract][Full Text] [Related]
29. Squalene epoxidase is a bona fide oncogene by amplification with clinical relevance in breast cancer.
Brown DN; Caffa I; Cirmena G; Piras D; Garuti A; Gallo M; Alberti S; Nencioni A; Ballestrero A; Zoppoli G
Sci Rep; 2016 Jan; 6():19435. PubMed ID: 26777065
[TBL] [Abstract][Full Text] [Related]
30. Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors.
Pollack JR; Sørlie T; Perou CM; Rees CA; Jeffrey SS; Lonning PE; Tibshirani R; Botstein D; Børresen-Dale AL; Brown PO
Proc Natl Acad Sci U S A; 2002 Oct; 99(20):12963-8. PubMed ID: 12297621
[TBL] [Abstract][Full Text] [Related]
31. DNA copy number alterations, gene expression changes and disease-free survival in patients with colorectal cancer: a 10 year follow-up.
Bigagli E; De Filippo C; Castagnini C; Toti S; Acquadro F; Giudici F; Fazi M; Dolara P; Messerini L; Tonelli F; Luceri C
Cell Oncol (Dordr); 2016 Dec; 39(6):545-558. PubMed ID: 27709558
[TBL] [Abstract][Full Text] [Related]
32. Nonamplification ERBB2 genomic alterations in 5605 cases of recurrent and metastatic breast cancer: An emerging opportunity for anti-HER2 targeted therapies.
Ross JS; Gay LM; Wang K; Ali SM; Chumsri S; Elvin JA; Bose R; Vergilio JA; Suh J; Yelensky R; Lipson D; Chmielecki J; Waintraub S; Leyland-Jones B; Miller VA; Stephens PJ
Cancer; 2016 Sep; 122(17):2654-62. PubMed ID: 27284958
[TBL] [Abstract][Full Text] [Related]
33. Genomic landscape of copy number aberrations enables the identification of oncogenic drivers in hepatocellular carcinoma.
Wang K; Lim HY; Shi S; Lee J; Deng S; Xie T; Zhu Z; Wang Y; Pocalyko D; Yang WJ; Rejto PA; Mao M; Park CK; Xu J
Hepatology; 2013 Aug; 58(2):706-17. PubMed ID: 23505090
[TBL] [Abstract][Full Text] [Related]
34. Multi-omics of 34 colorectal cancer cell lines - a resource for biomedical studies.
Berg KCG; Eide PW; Eilertsen IA; Johannessen B; Bruun J; Danielsen SA; Bjørnslett M; Meza-Zepeda LA; Eknæs M; Lind GE; Myklebost O; Skotheim RI; Sveen A; Lothe RA
Mol Cancer; 2017 Jul; 16(1):116. PubMed ID: 28683746
[TBL] [Abstract][Full Text] [Related]
35. GATA3 protein as a MUC1 transcriptional regulator in breast cancer cells.
Abba MC; Nunez MI; Colussi AG; Croce MV; Segal-Eiras A; Aldaz CM
Breast Cancer Res; 2006; 8(6):R64. PubMed ID: 17078870
[TBL] [Abstract][Full Text] [Related]
36. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
Zhang H; Stephens LC; Kumar R
Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
[TBL] [Abstract][Full Text] [Related]
37. Somatic Copy Number Alterations at Oncogenic Loci Show Diverse Correlations with Gene Expression.
Roszik J; Wu CJ; Siroy AE; Lazar AJ; Davies MA; Woodman SE; Kwong LN
Sci Rep; 2016 Jan; 6():19649. PubMed ID: 26787600
[TBL] [Abstract][Full Text] [Related]
38. Expression and prognosis analyses of the Tob/BTG antiproliferative (APRO) protein family in human cancers.
Bai Y; Qiao L; Xie N; Shi Y; Liu N; Wang J
PLoS One; 2017; 12(9):e0184902. PubMed ID: 28922388
[TBL] [Abstract][Full Text] [Related]
39. From oncogene to network addiction: the new frontier of cancer genomics and therapeutics.
Tonon G
Future Oncol; 2008 Aug; 4(4):569-77. PubMed ID: 18684067
[TBL] [Abstract][Full Text] [Related]
40. Systematic identification of genes with a cancer-testis expression pattern in 19 cancer types.
Wang C; Gu Y; Zhang K; Xie K; Zhu M; Dai N; Jiang Y; Guo X; Liu M; Dai J; Wu L; Jin G; Ma H; Jiang T; Yin R; Xia Y; Liu L; Wang S; Shen B; Huo R; Wang Q; Xu L; Yang L; Huang X; Shen H; Sha J; Hu Z
Nat Commun; 2016 Jan; 7():10499. PubMed ID: 26813108
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
